McGowan Institute for Regenerative Medicine

To realize the vast potential of tissue engineering and other techniques aimed at repairing damaged or diseased tissues and organs, the University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center established the McGowan Institute for Regenerative Medicine. The McGowan Institute serves as a single base of operations for the university’s leading scientists and clinical faculty working in the areas of tissue engineering, cellular therapies, and artificial and biohybrid organ devices.

The Institute’s mission includes the development of innovative clinical protocols as well as the pursuit of rapid commercial transfer of its technologies related to regenerative medicine. Also critical to the mission is the education and training of the next generation of scientists, clinicians and engineers who will be carrying the field forward toward the ultimate goal of patient benefit.

Mission:
The McGowan Institute’s Mission Statement is:
• To establish a national center of expertise in regenerative medicine focused on developing and delivering therapies that reestablish tissue and organ function impaired by disease, trauma or congenital abnormalities.
• To foster the generation of scientific knowledge in regenerative medicine and to share that knowledge with researchers, clinicians and the public through educational activities, training and publications.
• To educate and train scientists and engineers to pursue technologies related to regenerative medicine, and train a generation of clinicians in the implementation of regenerative therapies.
• To support the commercialization of technologies in regenerative medicine and thereby accelerate the translation of research discoveries to clinical implementation and patient benefit.